Literature DB >> 28439619

Association between bone mineral density, muscle strength, and vitamin D status in patients with myasthenia gravis: a cross-sectional study.

Y Guan1, F Lv2, Y Meng3, D Ma2, X Xu2, Y Song2, O Wang2, Y Jiang2, W Xia2, X Xing2, J Zhang4, M Li5.   

Abstract

Myasthenia gravis (MG) patients had low proximal hip BMD, which could be explained by reduced muscle strength, elevated bone resorption markers, vitamin D deficiency, and increased PTH levels in those with MG compared to controls.
INTRODUCTION: Muscle strength is closely correlated with bone mineral density (BMD) and vitamin D status. Here, we evaluated muscle strength, BMD, and vitamin D status in a large sample of Chinese patients with MG.
METHODS: In this cross-sectional survey, 86 patients with MG without glucocorticoid treatment and 86 healthy controls were included. Serum levels of 25-hydroxyvitamin D [25OHD], parathyroid hormone (PTH), bone turnover markers (BTMs), and BMD were measured and compared between the two groups. Grip strength and one-leg standing time (OLST) were also assessed in MG patients.
RESULTS: Low grip strength and short OLST were found in 11 (12.8%) and 12 (14.0%) MG patients, respectively. There were 3 (3.5%) MG patients with low bone mass for chronological age. Serum beta C-terminal telopeptide and PTH levels were higher (p < 0.001 and p = 0.001, respectively), and BMD at the femoral neck and trochanter were lower in MG patients (p < 0.001 and p < 0.001, respectively) compared to healthy controls. In patients with MG, grip strength was positively correlated with BMD. Serum 25OHD levels were lower in MG patients than in healthy controls (17.36 ± 6.64 vs. 22.11 ± 7.28 ng/ml, p < 0.001).
CONCLUSION: Grip strength was positively correlated with BMD in Chinese patients with MG. MG patients tended to have low proximal hip BMD, which may partially be explained by reduced muscle strength, vitamin D deficiency, increased PTH levels, and elevated bone resorption markers compared to controls.

Entities:  

Keywords:  25OHD; BMD; Bone turnover markers; Muscle strength; Myasthenia gravis

Mesh:

Substances:

Year:  2017        PMID: 28439619     DOI: 10.1007/s00198-017-4041-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  37 in total

1.  Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study.

Authors:  Robin M Daly; Claudia Gagnon; Zhong X Lu; Dianna J Magliano; David W Dunstan; Ken A Sikaris; Paul Z Zimmet; Peter R Ebeling; Jonathan E Shaw
Journal:  Clin Endocrinol (Oxf)       Date:  2012-07       Impact factor: 3.478

2.  RETRACTED: Etidronate for fracture prevention in amyotrophic lateral sclerosis: a randomized controlled trial.

Authors:  Yoshihiro Sato; Yoshiaki Honda; Jun Iwamoto
Journal:  Bone       Date:  2006-06-14       Impact factor: 4.398

3.  One-leg standing time and hip-fracture prediction.

Authors:  H Lundin; M Sääf; L-E Strender; S Nyren; S-E Johansson; H Salminen
Journal:  Osteoporos Int       Date:  2014-02-22       Impact factor: 4.507

4.  Muscle strength in myasthenia gravis.

Authors:  S Cejvanovic; J Vissing
Journal:  Acta Neurol Scand       Date:  2013-10-11       Impact factor: 3.209

5.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

Authors:  Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

6.  Relationship between vitamin D, parathyroid hormone, and bone health.

Authors:  A J Sai; R W Walters; X Fang; J C Gallagher
Journal:  J Clin Endocrinol Metab       Date:  2010-12-15       Impact factor: 5.958

7.  Diet, sun, and lifestyle as determinants of vitamin D status.

Authors:  Paul Lips; Natasja M van Schoor; Renate T de Jongh
Journal:  Ann N Y Acad Sci       Date:  2014-05-09       Impact factor: 5.691

Review 8.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

9.  Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy.

Authors:  Ann-Charlott Söderpalm; Per Magnusson; Anne-Christine Ahlander; Jón Karlsson; Anna-Karin Kroksmark; Már Tulinius; Diana Swolin-Eide
Journal:  Neuromuscul Disord       Date:  2007-07-12       Impact factor: 4.296

10.  Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study.

Authors:  Shingo Konno; Shigeaki Suzuki; Masayuki Masuda; Yuriko Nagane; Emiko Tsuda; Hiroyuki Murai; Tomihiro Imai; Toshiki Fujioka; Norihiro Suzuki; Kimiaki Utsugisawa
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

View more
  1 in total

1.  Evaluation of the Quantitative Myasthenia Gravis Score and Grip Strength in Chinese Patients With Myasthenia Gravis: An Observational Study.

Authors:  Jinghao Li; Senhui Weng; Sen Lin; Linwen Huang; Xiaojun Yang; Bo Liang; Jiaxin Lu; Qilong Jiang
Journal:  Front Neurol       Date:  2021-12-24       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.